PICC Capital Investment Management is a privately owned investment manager.
Business Model:
Revenue: $0
Employees: 0-0
Address:
City:
State:
Zip:
Country:
PICC Capital Investment Management is a privately owned investment manager.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
12/2021 | Svolt Energy Technology Co. | Series B | 0 |
4/2022 | METiS Pharmaceuticals | Series B | 0 |
3/2020 | Care Link | Series A | 1.4M |
4/2022 | Ingeek | Series B | - |
1/2018 | New Flow Technology | Series A | 18M |
12/2021 | Weishi Energy | Series A | 0 |
11/2022 | Asia Pacific Medical Group | Series A | - |
12/2021 | NeoCura | Series A | 0 |
12/2021 | METiS Pharmaceuticals | Series A | 0 |
9/2020 | XtalPi | Series C | 318.8M |
6/2022 | Doma Biopharmaceutical | Series A | 0 |
4/2022 | METiS Therapeutics | Series B | 0 |
12/2021 | Vastai Technologies | Series B | 0 |
5/2021 | GeneQuantum Healthcare | Series C | - |
1/2018 | MLog Tianqijia | Series B | 18M |
11/2022 | Atech Automotive Electronics | Series C | 0 |
1/2022 | Tongxin Medical Equipment | Series D | 100M |
4/2021 | Abogen Biosciences | Series B | 91.6M |
5/2021 | Jenscare Biotech | Venture Round | - |
10/2022 | GAC Aion New Energy Automobile | Series A | 0 |
6/2022 | Doma Biopharmaceutical | Series A | 0 |
4/2022 | Ingeek | Series B | - |
4/2022 | METiS Pharmaceuticals | Series B | 0 |
4/2022 | METiS Therapeutics | Series B | 0 |
1/2022 | Tongxin Medical Equipment | Series D | 0 |
12/2021 | NeoCura | Series A | 0 |
12/2021 | Vastai Technologies | Series B | 0 |
12/2021 | Weishi Energy | Series A | 0 |
12/2021 | METiS Pharmaceuticals | Series A | 0 |
12/2021 | Svolt Energy Technology Co. | Series B | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|